免疫学市場：薬剤クラス別、適応疾患別、流通チャネル別、地域別

世界の免疫学市場は、2025年には1,084億9,000万米ドルと推定され、2032年には2,460億4,000万米ドルに達すると予測され、2025～2032年にかけてCAGR12.4％で成長すると予測されています。

図.免疫学市場の地域別シェア（%）（2025年）

免疫学は、細菌やウイルスなどの外敵から身体を守る免疫システムの研究です。感染や病気から宿主を守る複雑な細胞や分子のメカニズムが関与しています。世界の免疫学市場には、疾病診断、医薬品開発、研究活動など様々な目的で使用される様々なアッセイ、キット、機器、ソフトウェアが含まれます。病院、研究機関、製薬会社、バイオテクノロジー会社などのエンドユーザー向けです。慢性疾患の増加、個別化医療への注目の高まり、バイオマーカーやコンパニオン診断の採用拡大により、市場は大きく成長しています。しかし、検査費用の高騰や規制上の問題は、市場参入者にとって課題となっています。イムノアッセイ技術の進歩、生物製剤産業の成長、ポイズドの普及は、近い将来の免疫学市場の成長を促進する可能性があります。

市場力学

世界の免疫学市場の成長は、がん、糖尿病、心血管障害などの慢性疾患の有病率の増加によって牽引されています。WHOのデータによると、2020年には世界の全死亡者の70％以上を慢性疾患が占めます。また、高齢者の増加も、加齢によって上記の疾患のリスクが高まるため、市場成長の原動力となります。精密医療への注目の高まりは、疾病管理におけるバイオマーカー、コンパニオン診断、免疫測定検査の開発と採用を後押ししています。このため、予測期間中は免疫学関連製品の需要が高まると予想されます。しかし、特に価格に敏感な新興国市場では、先進的検査に関連する高コストが大きな課題となる可能性があります。また、新製品承認のための厳しい規制プロセスも、参入企業の市場参入を遅らせる可能性があります。特にがん免疫学と免疫療法のセグメントでは研究活動が活発化しており、有利な機会をもたらす可能性があります。アッセイ開発における継続的な技術進歩も、免疫学製品の用途を拡大する可能性があります。

本調査の主要特徴

• 本レポートでは、世界の免疫学市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域による展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 本レポートでは、企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の免疫学市場における主要企業をプロファイルしています。
• 本レポートから洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
• 免疫学の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この産業の様々な利害関係者に対応しています。
• 利害関係者は、世界の免疫学市場分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• 一貫型機会マップ（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 規制シナリオ
• 買収と提携のシナリオ
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界の免疫学市場-コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界の免疫学市場、薬剤クラス別、2020～2032年（10億米ドル）

• イントロダクション
• モノクローナル抗体（mAb）
• 融合タンパク質
• 免疫抑制剤
• ポリクローナル抗体（pAb）
• その他

第6章 世界の免疫学市場、適応疾患別、2020～2032年（10億米ドル）

• イントロダクション
• 関節リウマチ
• 乾癬性関節炎
• 尋常性乾癬
• 強直性脊椎炎
• 炎症性腸疾患
• 臓器拒絶反応の予防
• その他

第7章 世界の免疫学市場、流通チャネル別、2020～2032年（10億米ドル）

• イントロダクション
• 病院薬局
• 小売薬局
• オンライン薬局

第8章 世界の免疫学市場、地域別、2020～2032年（10億米ドル）

• イントロダクション
• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• 企業プロファイル
  • AbbVie Inc.
  • Johnson & Johnson
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Novartis International AG
  • Bristol-Myers Squibb Company
  • Merck &Co., Inc.
  • AstraZeneca PLC
  • Sanofi
  • GlaxoSmithKline plc
  • UCB SA
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Celgene Corporation
  • Biogen Inc.
  • Regeneron Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.

第10章 アナリストの推奨事項

• 隆盛と衰退
• 一貫型機会マップ

第11章 参考文献と調査手法

• 参考文献
• 調査手法

Global Immunology Market is estimated to be valued at USD 108.49 Bn in 2025 and is expected to reach USD 246.04 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.4% from 2025 to 2032.

Figure. Immunology Market Share (%), By Region 2025

Immunology is the study of the immune system, which protects the body from foreign invaders like bacteria and viruses. It involves complex cellular and molecular mechanisms that defend the host from infection or disease. Global immunology market encompasses various assays, kits, instruments and software that are used for various purposes like disease diagnosis, drug development and research activities. It caters to end users like hospitals, research institutes, pharmaceutical and biotechnology companies. The market has witnessed significant growth due to increasing prevalence of chronic diseases, rising focus on personalized medicine and growing adoption of biomarkers and companion diagnostics. However, high costs of tests and regulatory issues can pose challenges to market players. The advancements in immunoassay technologies, growing biologics industry, and popularity of poised can drive the immunology market growth in the near future.

Market Dynamics:

Global immunology market growth is driven by increasing prevalence of chronic diseases like cancer, diabetes and cardiovascular disorders. According to the data from WHO, chronic diseases accounted for over 70% of all deaths globally in 2020. Growing geriatric population can also drive the market growth as age increases the risk of above-mentioned conditions. Rising focus on precision medicine has bolstered the development and adoption of biomarkers, companion diagnostics and immunoassay tests in disease management. This is expected to boost demand for immunology products over the forecast period. However, high costs associated with advanced tests can pose significant challenges, especially in price-sensitive developing markets. Stringent regulatory processes for new product approvals can also delay market entry for players. Rising research activities especially in the fields of cancer immunology and immunotherapy can present lucrative opportunities. Continuous technological advancements in assay development can also expand the applications of immunology products.

Key Features of the Study:

• This report provides in-depth analysis of the global immunology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global immunology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Abbott, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Sysmex Corporation, Beckman Coulter Inc, Danaher Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global immunology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunology market.

Detailed Segmentation-

• By Drug Class
  • Monoclonal Antibody (mAb)
  • Fusion Proteins
  • Immunosuppressants
  • Polyclonal Antibody (pAb)
  • Others
• By Disease Indication
  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Plaque Psoriasis
  • Ankylosing Spondylitis
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • AbbVie Inc.
  • Johnson & Johnson
  • Amgen Inc.
  • Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Novartis International AG
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • Sanofi
  • GlaxoSmithKline plc
  • UCB S.A.
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Celgene Corporation
  • Biogen Inc.
  • Regeneron Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Disease Indication
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Immunology Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Immunology Market, By Drug Class, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Monoclonal Antibody (mAb)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Fusion Proteins
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Immunosuppressants
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Polyclonal Antibody (pAb)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Immunology Market, By Disease Indication, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Rheumatoid Arthritis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Psoriatic Arthritis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Plaque Psoriasis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ankylosing Spondylitis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Inflammatory Bowel Disease
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Prophylaxis of Organ Rejection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Immunology Market, By Distribution Channel, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Immunology Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • AbbVie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F. Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Novartis International AG
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • Sanofi
  • GlaxoSmithKline plc
  • UCB S.A.
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Celgene Corporation
  • Biogen Inc.
  • Regeneron Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact